Complement Subcomponent C1q Modulation of TNF‐α Binding to L929 Cells for Enhanced TNF‐Mediated Cytotoxicity

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Scandinavian Journal of Immunology

• Publication date

  1996-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-3083.1992.d01-284.xPMID 8711421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for endogenous C1q modulates TNF-alpha receptor synthesis and autocrine binding of TNF-alpha associated with lipid A activation of murine macrophages for nitric oxide production.

  1996cited by this paper
• Transfection of L929 cells with complement subcomponent C1q B-chain antisense cDNA inhibits tumor necrosis factor-alpha binding to mediate cytotoxicity and nitric oxide generation.

  1996cited by this paper
• A novel domain within the 55 kd TNF receptor signals cell death.

  1993cited by this paper
• Inhibitor of C1q secretion suppresses the macrophage response to lipid A for nitric oxide but not for TNF production: evidence for a role of C1q in autocrine binding of TNF.

  1993cited by this paper
• Kinetics of the biosynthesis of complement subcomponent C1q by murine macrophages: effects of stimulation by interferon-gamma.

  1991cited by this paper
• Exogenous C1q reconstitutes a secondary deficiency of C5-deficient AKR mouse macrophages for FcR-dependent cellular cytotoxicity and phagocytosis.

  1991cited by this paper
• Kinetics of the Biosynthesis of Complement Subcomponent C1q by Murine Macrophages: LPS, Immune Complexes, and Zymosan Alone and in Combination With Interferon‐γ

  1991cited by this paper
• Kinetics of the Biosynthesis of Complement Subcomponent C1q by Murine Macrophages: Effects of Stimulation by Interferon-γ

  1991cited by this paper
• Reconstitution of a deficiency of AKR mouse macrophages for their response to lipid A activation for tumor cytotoxicity by complement subcomponent C1q: role of IFN-gamma.

  1991cited by this paper
• Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.

  1991cited by this paper
• Kinetics of the biosynthesis of complement subcomponent C1q by murine macrophages: LPS, immune complexes, and zymosan alone and in combination with interferon-gamma.

  1991cited by this paper
• Participation of C1q and its receptor in adherence of human diploid fibroblast.

  1990cited by this paper
• Platelet C1q receptor interactions with collagen- and C1q-coated surfaces.

  1990cited by this paper
• Inhibitors of C1q biosynthesis suppress activation of murine macrophages for both antibody-independent and antibody-dependent tumor cytotoxicity.

  1990cited by this paper
• Reconstitution of murine resident peritoneal macrophages for antibody-dependent cellular cytotoxicity by homologous serum Clq.

  1989cited by this paper
• Exogenous C1q reconstitutes resident but not inflammatory mouse peritoneal macrophages for Fc receptor-dependent cellular cytotoxicity and phagocytosis. Relationship to endogenous C1q availability.

  1989cited by this paper
• C1q component of complement binds to fibrinogen and fibrin.

  1988cited by this paper
• C1q enhances the phagocytosis of Cryptococcus neoformans blastospores by human monocytes.

  1988cited by this paper
• C1q induces chemotaxis and K+ conductance activation coupled to increased cytosolic Ca2+ in mouse fibroblasts.

  1988cited by this paper
• Clq acts synergistically with phorbol dibutyrate to activate CR1‐mediated phagocytosis by human mononuclear phagocytes

  1988cited by this paper
• Effects of inhibitors of C1q biosynthesis on macrophage Fc receptor subclass-mediated antibody-dependent cellular cytotoxicity and phagocytosis.

  1987cited by this paper
• Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages.

  1987cited by this paper
• Characterization of C1q receptor expression on human phagocytic cells: effects of PDBu and fMLP.

  1986cited by this paper
• Effects of soluble aggregates of IgG on the binding, uptake and degradation of the Clq subcomponent of complement by adherent guinea pig peritoneal macrophages

  1985cited by this paper
• Fibronectin binding to complement subcomponent C1q. Localization of their respective binding sites.

  1985cited by this paper
• The C1q subunit of the first component of complement binds to laminin: a mechanism for the deposition and retention of immune complexes in basement membrane.

  1985cited by this paper
• Comparison of in vitro cell cytotoxic assays for tumor necrosis factor.

  1984cited by this paper
• Biosynthesis of the collagen-like C1q molecule and its receptor functions for Fc and polyanionic molecules on macrophages.

  1983cited by this paper
• Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.

  1983cited by this paper
• C1Q receptors on cultured human gingival fibroblasts: analysis of binding properties.

  1983cited by this paper
• Distinct genes for fibroblast and serum C1q

  1981cited by this paper
• Interaction of collagen with C1q via its collagen-like portion.

  1981cited by this paper
• Purification and radiolabeling of human C1q.

  1981cited by this paper
• Analysis of receptor-mediated C1q binding to human peripheral blood mononuclear cells.

  1980cited by this paper

• Differences in binding and effector functions between classes of TNF antagonists.

  2009cites this paper
• Investigation of the functional characteristics of antibodies to therapeutic anti-human tumor necrosis factor alpha monoclonal antibody.

  2007cites this paper
• Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer

  2005cites this paper
• Cyclosporin A Suppresses the Induction of Nitric Oxide Synthesis in Interferon‐γ‐Treated L929 Fibroblasts

  1999cites this paper
• Glomerular Binding Antibodies in Systemic Lupus Erythematosus

  1999cites this paper